The global market for Velpatasvir API is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Velpatasvir API market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Velpatasvir API market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Velpatasvir API market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Velpatasvir API market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Velpatasvir API players cover Mylan, NEWEDGE Overseas, Hetero Drugs, Mangalam Drugs & Organics Ltd and Aspen Biopharma Labs, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Velpatasvir API market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Velpatasvir API market, with both quantitative and qualitative data, to help readers understand how the Velpatasvir API market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in Kg.
Market Segmentation:
The study segments the Velpatasvir API market and forecasts the market size by Purity (Above 98 % and Above 99 %,), by Application (Tablets and Others.), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by purity
Above 98 %
Above 99 %
Segmentation by application
Tablets
Others
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Mylan
NEWEDGE Overseas
Hetero Drugs
Mangalam Drugs & Organics Ltd
Aspen Biopharma Labs
Aspire Lifesciences Pvt Ltd
Changzhou Pharmaceutical Factory
Bulat Pharmaceutical
Chapter Introduction
Chapter 1: Scope of Velpatasvir API, Research Methodology, etc.
Chapter 2: Executive Summary, global Velpatasvir API market size (sales and revenue) and CAGR, Velpatasvir API market size by region, by purity, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Velpatasvir API sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Velpatasvir API sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by purity, and purity.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Velpatasvir API market size forecast by region, by country, by purity, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Mylan, NEWEDGE Overseas, Hetero Drugs, Mangalam Drugs & Organics Ltd, Aspen Biopharma Labs, Aspire Lifesciences Pvt Ltd, Changzhou Pharmaceutical Factory and Bulat Pharmaceutical, etc.
Chapter 14: Research Findings and Conclusion
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Velpatasvir API Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Velpatasvir API by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Velpatasvir API by Country/Region, 2017, 2022 & 2028
2.2 Velpatasvir API Segment by Purity
2.2.1 Above 98 %
2.2.2 Above 99 %
2.3 Velpatasvir API Sales by Purity
2.3.1 Global Velpatasvir API Sales Market Share by Purity (2017-2022)
2.3.2 Global Velpatasvir API Revenue and Market Share by Purity (2017-2022)
2.3.3 Global Velpatasvir API Sale Price by Purity (2017-2022)
2.4 Velpatasvir API Segment by Application
2.4.1 Tablets
2.4.2 Others
2.5 Velpatasvir API Sales by Application
2.5.1 Global Velpatasvir API Sale Market Share by Application (2017-2022)
2.5.2 Global Velpatasvir API Revenue and Market Share by Application (2017-2022)
2.5.3 Global Velpatasvir API Sale Price by Application (2017-2022)
3 Global Velpatasvir API by Company
3.1 Global Velpatasvir API Breakdown Data by Company
3.1.1 Global Velpatasvir API Annual Sales by Company (2020-2022)
3.1.2 Global Velpatasvir API Sales Market Share by Company (2020-2022)
3.2 Global Velpatasvir API Annual Revenue by Company (2020-2022)
3.2.1 Global Velpatasvir API Revenue by Company (2020-2022)
3.2.2 Global Velpatasvir API Revenue Market Share by Company (2020-2022)
3.3 Global Velpatasvir API Sale Price by Company
3.4 Key Manufacturers Velpatasvir API Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Velpatasvir API Product Location Distribution
3.4.2 Players Velpatasvir API Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Velpatasvir API by Geographic Region
4.1 World Historic Velpatasvir API Market Size by Geographic Region (2017-2022)
4.1.1 Global Velpatasvir API Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Velpatasvir API Annual Revenue by Geographic Region
4.2 World Historic Velpatasvir API Market Size by Country/Region (2017-2022)
4.2.1 Global Velpatasvir API Annual Sales by Country/Region (2017-2022)
4.2.2 Global Velpatasvir API Annual Revenue by Country/Region
4.3 Americas Velpatasvir API Sales Growth
4.4 APAC Velpatasvir API Sales Growth
4.5 Europe Velpatasvir API Sales Growth
4.6 Middle East & Africa Velpatasvir API Sales Growth
5 Americas
5.1 Americas Velpatasvir API Sales by Country
5.1.1 Americas Velpatasvir API Sales by Country (2017-2022)
5.1.2 Americas Velpatasvir API Revenue by Country (2017-2022)
5.2 Americas Velpatasvir API Sales by Purity
5.3 Americas Velpatasvir API Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Velpatasvir API Sales by Region
6.1.1 APAC Velpatasvir API Sales by Region (2017-2022)
6.1.2 APAC Velpatasvir API Revenue by Region (2017-2022)
6.2 APAC Velpatasvir API Sales by Purity
6.3 APAC Velpatasvir API Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Velpatasvir API by Country
7.1.1 Europe Velpatasvir API Sales by Country (2017-2022)
7.1.2 Europe Velpatasvir API Revenue by Country (2017-2022)
7.2 Europe Velpatasvir API Sales by Purity
7.3 Europe Velpatasvir API Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Velpatasvir API by Country
8.1.1 Middle East & Africa Velpatasvir API Sales by Country (2017-2022)
8.1.2 Middle East & Africa Velpatasvir API Revenue by Country (2017-2022)
8.2 Middle East & Africa Velpatasvir API Sales by Purity
8.3 Middle East & Africa Velpatasvir API Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Velpatasvir API
10.3 Manufacturing Process Analysis of Velpatasvir API
10.4 Industry Chain Structure of Velpatasvir API
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Velpatasvir API Distributors
11.3 Velpatasvir API Customer
12 World Forecast Review for Velpatasvir API by Geographic Region
12.1 Global Velpatasvir API Market Size Forecast by Region
12.1.1 Global Velpatasvir API Forecast by Region (2023-2028)
12.1.2 Global Velpatasvir API Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Velpatasvir API Forecast by Purity
12.7 Global Velpatasvir API Forecast by Application
13 Key Players Analysis
13.1 Mylan
13.1.1 Mylan Company Information
13.1.2 Mylan Velpatasvir API Product Offered
13.1.3 Mylan Velpatasvir API Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Mylan Main Business Overview
13.1.5 Mylan Latest Developments
13.2 NEWEDGE Overseas
13.2.1 NEWEDGE Overseas Company Information
13.2.2 NEWEDGE Overseas Velpatasvir API Product Offered
13.2.3 NEWEDGE Overseas Velpatasvir API Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 NEWEDGE Overseas Main Business Overview
13.2.5 NEWEDGE Overseas Latest Developments
13.3 Hetero Drugs
13.3.1 Hetero Drugs Company Information
13.3.2 Hetero Drugs Velpatasvir API Product Offered
13.3.3 Hetero Drugs Velpatasvir API Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Hetero Drugs Main Business Overview
13.3.5 Hetero Drugs Latest Developments
13.4 Mangalam Drugs & Organics Ltd
13.4.1 Mangalam Drugs & Organics Ltd Company Information
13.4.2 Mangalam Drugs & Organics Ltd Velpatasvir API Product Offered
13.4.3 Mangalam Drugs & Organics Ltd Velpatasvir API Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Mangalam Drugs & Organics Ltd Main Business Overview
13.4.5 Mangalam Drugs & Organics Ltd Latest Developments
13.5 Aspen Biopharma Labs
13.5.1 Aspen Biopharma Labs Company Information
13.5.2 Aspen Biopharma Labs Velpatasvir API Product Offered
13.5.3 Aspen Biopharma Labs Velpatasvir API Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Aspen Biopharma Labs Main Business Overview
13.5.5 Aspen Biopharma Labs Latest Developments
13.6 Aspire Lifesciences Pvt Ltd
13.6.1 Aspire Lifesciences Pvt Ltd Company Information
13.6.2 Aspire Lifesciences Pvt Ltd Velpatasvir API Product Offered
13.6.3 Aspire Lifesciences Pvt Ltd Velpatasvir API Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Aspire Lifesciences Pvt Ltd Main Business Overview
13.6.5 Aspire Lifesciences Pvt Ltd Latest Developments
13.7 Changzhou Pharmaceutical Factory
13.7.1 Changzhou Pharmaceutical Factory Company Information
13.7.2 Changzhou Pharmaceutical Factory Velpatasvir API Product Offered
13.7.3 Changzhou Pharmaceutical Factory Velpatasvir API Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Changzhou Pharmaceutical Factory Main Business Overview
13.7.5 Changzhou Pharmaceutical Factory Latest Developments
13.8 Bulat Pharmaceutical
13.8.1 Bulat Pharmaceutical Company Information
13.8.2 Bulat Pharmaceutical Velpatasvir API Product Offered
13.8.3 Bulat Pharmaceutical Velpatasvir API Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Bulat Pharmaceutical Main Business Overview
13.8.5 Bulat Pharmaceutical Latest Developments
14 Research Findings and Conclusion
List of Tables
Table 1. Velpatasvir API Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Velpatasvir API Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Above 98 %
Table 4. Major Players of Above 99 %
Table 5. Global Velpatasvir API Sales by Purity (2017-2022) & (Kg)
Table 6. Global Velpatasvir API Sales Market Share by Purity (2017-2022)
Table 7. Global Velpatasvir API Revenue by Purity (2017-2022) & ($ million)
Table 8. Global Velpatasvir API Revenue Market Share by Purity (2017-2022)
Table 9. Global Velpatasvir API Sale Price by Purity (2017-2022) & (US$/Kg)
Table 10. Global Velpatasvir API Sales by Application (2017-2022) & (Kg)
Table 11. Global Velpatasvir API Sales Market Share by Application (2017-2022)
Table 12. Global Velpatasvir API Revenue by Application (2017-2022)
Table 13. Global Velpatasvir API Revenue Market Share by Application (2017-2022)
Table 14. Global Velpatasvir API Sale Price by Application (2017-2022) & (US$/Kg)
Table 15. Global Velpatasvir API Sales by Company (2020-2022) & (Kg)
Table 16. Global Velpatasvir API Sales Market Share by Company (2020-2022)
Table 17. Global Velpatasvir API Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Velpatasvir API Revenue Market Share by Company (2020-2022)
Table 19. Global Velpatasvir API Sale Price by Company (2020-2022) & (US$/Kg)
Table 20. Key Manufacturers Velpatasvir API Producing Area Distribution and Sales Area
Table 21. Players Velpatasvir API Products Offered
Table 22. Velpatasvir API Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Velpatasvir API Sales by Geographic Region (2017-2022) & (Kg)
Table 26. Global Velpatasvir API Sales Market Share Geographic Region (2017-2022)
Table 27. Global Velpatasvir API Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Velpatasvir API Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Velpatasvir API Sales by Country/Region (2017-2022) & (Kg)
Table 30. Global Velpatasvir API Sales Market Share by Country/Region (2017-2022)
Table 31. Global Velpatasvir API Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Velpatasvir API Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Velpatasvir API Sales by Country (2017-2022) & (Kg)
Table 34. Americas Velpatasvir API Sales Market Share by Country (2017-2022)
Table 35. Americas Velpatasvir API Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Velpatasvir API Revenue Market Share by Country (2017-2022)
Table 37. Americas Velpatasvir API Sales by Type (2017-2022) & (Kg)
Table 38. Americas Velpatasvir API Sales Market Share by Purity (2017-2022)
Table 39. Americas Velpatasvir API Sales by Application (2017-2022) & (Kg)
Table 40. Americas Velpatasvir API Sales Market Share by Application (2017-2022)
Table 41. APAC Velpatasvir API Sales by Region (2017-2022) & (Kg)
Table 42. APAC Velpatasvir API Sales Market Share by Region (2017-2022)
Table 43. APAC Velpatasvir API Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Velpatasvir API Revenue Market Share by Region (2017-2022)
Table 45. APAC Velpatasvir API Sales by Purity (2017-2022) & (Kg)
Table 46. APAC Velpatasvir API Sales Market Share by Purity (2017-2022)
Table 47. APAC Velpatasvir API Sales by Application (2017-2022) & (Kg)
Table 48. APAC Velpatasvir API Sales Market Share by Application (2017-2022)
Table 49. Europe Velpatasvir API Sales by Country (2017-2022) & (Kg)
Table 50. Europe Velpatasvir API Sales Market Share by Country (2017-2022)
Table 51. Europe Velpatasvir API Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Velpatasvir API Revenue Market Share by Country (2017-2022)
Table 53. Europe Velpatasvir API Sales by Type (2017-2022) & (Kg)
Table 54. Europe Velpatasvir API Sales Market Share by Purity (2017-2022)
Table 55. Europe Velpatasvir API Sales by Application (2017-2022) & (Kg)
Table 56. Europe Velpatasvir API Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Velpatasvir API Sales by Country (2017-2022) & (Kg)
Table 58. Middle East & Africa Velpatasvir API Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Velpatasvir API Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Velpatasvir API Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Velpatasvir API Sales by Purity (2017-2022) & (Kg)
Table 62. Middle East & Africa Velpatasvir API Sales Market Share by Purity (2017-2022)
Table 63. Middle East & Africa Velpatasvir API Sales by Application (2017-2022) & (Kg)
Table 64. Middle East & Africa Velpatasvir API Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Velpatasvir API
Table 66. Key Market Challenges & Risks of Velpatasvir API
Table 67. Key Industry Trends of Velpatasvir API
Table 68. Velpatasvir API Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Velpatasvir API Distributors List
Table 71. Velpatasvir API Customer List
Table 72. Global Velpatasvir API Sales Forecast by Region (2023-2028) & (Kg)
Table 73. Global Velpatasvir API Sales Market Forecast by Region
Table 74. Global Velpatasvir API Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Velpatasvir API Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Velpatasvir API Sales Forecast by Country (2023-2028) & (Kg)
Table 77. Americas Velpatasvir API Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Velpatasvir API Sales Forecast by Region (2023-2028) & (Kg)
Table 79. APAC Velpatasvir API Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Velpatasvir API Sales Forecast by Country (2023-2028) & (Kg)
Table 81. Europe Velpatasvir API Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Velpatasvir API Sales Forecast by Country (2023-2028) & (Kg)
Table 83. Middle East & Africa Velpatasvir API Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Velpatasvir API Sales Forecast by Purity (2023-2028) & (Kg)
Table 85. Global Velpatasvir API Sales Market Share Forecast by Purity (2023-2028)
Table 86. Global Velpatasvir API Revenue Forecast by Purity (2023-2028) & ($ Millions)
Table 87. Global Velpatasvir API Revenue Market Share Forecast by Purity (2023-2028)
Table 88. Global Velpatasvir API Sales Forecast by Application (2023-2028) & (Kg)
Table 89. Global Velpatasvir API Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Velpatasvir API Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Velpatasvir API Revenue Market Share Forecast by Application (2023-2028)
Table 92. Mylan Basic Information, Velpatasvir API Manufacturing Base, Sales Area and Its Competitors
Table 93. Mylan Velpatasvir API Product Offered
Table 94. Mylan Velpatasvir API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 95. Mylan Main Business
Table 96. Mylan Latest Developments
Table 97. NEWEDGE Overseas Basic Information, Velpatasvir API Manufacturing Base, Sales Area and Its Competitors
Table 98. NEWEDGE Overseas Velpatasvir API Product Offered
Table 99. NEWEDGE Overseas Velpatasvir API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 100. NEWEDGE Overseas Main Business
Table 101. NEWEDGE Overseas Latest Developments
Table 102. Hetero Drugs Basic Information, Velpatasvir API Manufacturing Base, Sales Area and Its Competitors
Table 103. Hetero Drugs Velpatasvir API Product Offered
Table 104. Hetero Drugs Velpatasvir API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 105. Hetero Drugs Main Business
Table 106. Hetero Drugs Latest Developments
Table 107. Mangalam Drugs & Organics Ltd Basic Information, Velpatasvir API Manufacturing Base, Sales Area and Its Competitors
Table 108. Mangalam Drugs & Organics Ltd Velpatasvir API Product Offered
Table 109. Mangalam Drugs & Organics Ltd Velpatasvir API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 110. Mangalam Drugs & Organics Ltd Main Business
Table 111. Mangalam Drugs & Organics Ltd Latest Developments
Table 112. Aspen Biopharma Labs Basic Information, Velpatasvir API Manufacturing Base, Sales Area and Its Competitors
Table 113. Aspen Biopharma Labs Velpatasvir API Product Offered
Table 114. Aspen Biopharma Labs Velpatasvir API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 115. Aspen Biopharma Labs Main Business
Table 116. Aspen Biopharma Labs Latest Developments
Table 117. Aspire Lifesciences Pvt Ltd Basic Information, Velpatasvir API Manufacturing Base, Sales Area and Its Competitors
Table 118. Aspire Lifesciences Pvt Ltd Velpatasvir API Product Offered
Table 119. Aspire Lifesciences Pvt Ltd Velpatasvir API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 120. Aspire Lifesciences Pvt Ltd Main Business
Table 121. Aspire Lifesciences Pvt Ltd Latest Developments
Table 122. Changzhou Pharmaceutical Factory Basic Information, Velpatasvir API Manufacturing Base, Sales Area and Its Competitors
Table 123. Changzhou Pharmaceutical Factory Velpatasvir API Product Offered
Table 124. Changzhou Pharmaceutical Factory Velpatasvir API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 125. Changzhou Pharmaceutical Factory Main Business
Table 126. Changzhou Pharmaceutical Factory Latest Developments
Table 127. Bulat Pharmaceutical Basic Information, Velpatasvir API Manufacturing Base, Sales Area and Its Competitors
Table 128. Bulat Pharmaceutical Velpatasvir API Product Offered
Table 129. Bulat Pharmaceutical Velpatasvir API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 130. Bulat Pharmaceutical Main Business
Table 131. Bulat Pharmaceutical Latest Developments
List of Figures
Figure 1. Picture of Velpatasvir API
Figure 2. Velpatasvir API Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Velpatasvir API Sales Growth Rate 2017-2028 (Kg)
Figure 7. Global Velpatasvir API Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Velpatasvir API Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Above 98 %
Figure 10. Product Picture of Above 99 %
Figure 11. Global Velpatasvir API Sales Market Share by Purity in 2021
Figure 12. Global Velpatasvir API Revenue Market Share by Purity (2017-2022)
Figure 13. Velpatasvir API Consumed in Tablets
Figure 14. Global Velpatasvir API Market: Tablets (2017-2022) & (Kg)
Figure 15. Velpatasvir API Consumed in Others
Figure 16. Global Velpatasvir API Market: Others (2017-2022) & (Kg)
Figure 17. Global Velpatasvir API Sales Market Share by Application (2017-2022)
Figure 18. Global Velpatasvir API Revenue Market Share by Application in 2021
Figure 19. Velpatasvir API Revenue Market by Company in 2021 ($ Million)
Figure 20. Global Velpatasvir API Revenue Market Share by Company in 2021
Figure 21. Global Velpatasvir API Sales Market Share by Geographic Region (2017-2022)
Figure 22. Global Velpatasvir API Revenue Market Share by Geographic Region in 2021
Figure 23. Global Velpatasvir API Sales Market Share by Region (2017-2022)
Figure 24. Global Velpatasvir API Revenue Market Share by Country/Region in 2021
Figure 25. Americas Velpatasvir API Sales 2017-2022 (Kg)
Figure 26. Americas Velpatasvir API Revenue 2017-2022 ($ Millions)
Figure 27. APAC Velpatasvir API Sales 2017-2022 (Kg)
Figure 28. APAC Velpatasvir API Revenue 2017-2022 ($ Millions)
Figure 29. Europe Velpatasvir API Sales 2017-2022 (Kg)
Figure 30. Europe Velpatasvir API Revenue 2017-2022 ($ Millions)
Figure 31. Middle East & Africa Velpatasvir API Sales 2017-2022 (Kg)
Figure 32. Middle East & Africa Velpatasvir API Revenue 2017-2022 ($ Millions)
Figure 33. Americas Velpatasvir API Sales Market Share by Country in 2021
Figure 34. Americas Velpatasvir API Revenue Market Share by Country in 2021
Figure 35. United States Velpatasvir API Revenue Growth 2017-2022 ($ Millions)
Figure 36. Canada Velpatasvir API Revenue Growth 2017-2022 ($ Millions)
Figure 37. Mexico Velpatasvir API Revenue Growth 2017-2022 ($ Millions)
Figure 38. Brazil Velpatasvir API Revenue Growth 2017-2022 ($ Millions)
Figure 39. APAC Velpatasvir API Sales Market Share by Region in 2021
Figure 40. APAC Velpatasvir API Revenue Market Share by Regions in 2021
Figure 41. China Velpatasvir API Revenue Growth 2017-2022 ($ Millions)
Figure 42. Japan Velpatasvir API Revenue Growth 2017-2022 ($ Millions)
Figure 43. South Korea Velpatasvir API Revenue Growth 2017-2022 ($ Millions)
Figure 44. Southeast Asia Velpatasvir API Revenue Growth 2017-2022 ($ Millions)
Figure 45. India Velpatasvir API Revenue Growth 2017-2022 ($ Millions)
Figure 46. Australia Velpatasvir API Revenue Growth 2017-2022 ($ Millions)
Figure 47. Europe Velpatasvir API Sales Market Share by Country in 2021
Figure 48. Europe Velpatasvir API Revenue Market Share by Country in 2021
Figure 49. Germany Velpatasvir API Revenue Growth 2017-2022 ($ Millions)
Figure 50. France Velpatasvir API Revenue Growth 2017-2022 ($ Millions)
Figure 51. UK Velpatasvir API Revenue Growth 2017-2022 ($ Millions)
Figure 52. Italy Velpatasvir API Revenue Growth 2017-2022 ($ Millions)
Figure 53. Russia Velpatasvir API Revenue Growth 2017-2022 ($ Millions)
Figure 54. Middle East & Africa Velpatasvir API Sales Market Share by Country in 2021
Figure 55. Middle East & Africa Velpatasvir API Revenue Market Share by Country in 2021
Figure 56. Egypt Velpatasvir API Revenue Growth 2017-2022 ($ Millions)
Figure 57. South Africa Velpatasvir API Revenue Growth 2017-2022 ($ Millions)
Figure 58. Israel Velpatasvir API Revenue Growth 2017-2022 ($ Millions)
Figure 59. Turkey Velpatasvir API Revenue Growth 2017-2022 ($ Millions)
Figure 60. GCC Country Velpatasvir API Revenue Growth 2017-2022 ($ Millions)
Figure 61. Manufacturing Cost Structure Analysis of Velpatasvir API in 2021
Figure 62. Manufacturing Process Analysis of Velpatasvir API
Figure 63. Industry Chain Structure of Velpatasvir API
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles
Global Graphitized Carbon Black (GCB) Ma..
Graphitized carbon black is a black particle that can be use..
+16467917070US (Toll Free)